XUEGANG YANG1,#, XIANHONG XIANG2,3,#, GUOHUI XU1, SHI ZHOU3, TIANZHI AN3,4,*, ZHI HUANG3,4,*
Oncology Research, Vol.32, No.1, pp. 213-226, 2024, DOI:10.32604/or.2023.030768
- 15 November 2023
Abstract Hepatocellular carcinoma (HCC), a common malignancy worldwide, still lacks effective clinical treatment. The study aimed to investigate the oncogenes that affect the progression of HCC and their possible mechanisms. In our study, we initially confirmed a higher level of PRDX2 in the bile of HCC patients compared to those with choledocholithiasis by 2-DE, LC-MS, and ELISA. Subsequently, we demonstrated the high expression of peroxiredoxin 2 (PRDX2) in HCC based on the TCGA database and clinical sample analysis. Furthermore, PRDX2 overexpression enhanced the viability of HCC cells. And PRDX2 silencing induced senescence of HCC cells. In vivo, More >
Login
Register
